An Observational Study of Dose Dense Chemotherapy With Lipegfilgrastim Support
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2018
At a glance
- Drugs Lipegfilgrastim (Primary)
- Indications Early breast cancer; Neutropenia
- Focus Adverse reactions
- 09 Feb 2018 Status changed from active, no longer recruiting to completed.
- 22 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 12 Dec 2015 Trial design presented at the 38th Annual San Antonio Breast Cancer Symposium.